Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

9.1%

1 terminated/withdrawn out of 11 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

27%

3 trials in Phase 3/4

Results Transparency

50%

3 of 6 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A

4(40.0%)

Phase 2

3(30.0%)

Phase 3

2(20.0%)

Phase 4

1(10.0%)

10Total

N/A(4)

Phase 2(3)

Phase 3(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT02403843Completed

RNS® System Epilepsy Post-Approval Study

Role: lead

NCT03868670Not ApplicableActive Not Recruiting

Responsive Neurostimulation For Loss Of Control Eating

Role: collaborator

NCT05339126Phase 2Active Not Recruiting

RNS System LGS Feasibility Study

Role: lead

NCT05120635Not ApplicableRecruiting

Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans

Role: collaborator

NCT02781129Not ApplicableCompleted

Navigation and Free Recall in Chronically Implanted Humans

Role: collaborator

NCT05147571Phase 3Active Not Recruiting

RNS System NAUTILUS Study

Role: lead

NCT04839601Not ApplicableTerminated

RNS System RESPONSE Study

Role: lead

NCT00572195Phase 4Completed

RNS® System LTT Study

Role: lead

NCT00079781Phase 2Completed

RNS® System Feasibility Study

Role: lead

NCT00264810Phase 3Completed

RNS® System Pivotal Study

Role: lead

NCT00158067Phase 2Completed

Study of an External Responsive Neurostimulator System on Epileptiform Activity

Role: lead

All 11 trials loaded